Cefilavancin

Cefilavancin (TD-1792) is an experimental antibiotic medication developed for the treatment of bacterial infections such as drug-resistant strains of Staphylococcus aureus.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cefilavancin (TD-1792) is an experimental antibiotic medication developed for the treatment of bacterial infections such as drug-resistant strains of Staphylococcus aureus. It is a prodrug which is also a codrug, injected intravenously and then cleaved inside the body to two active components, one of which is a modified form of vancomycin and the other a cephalosporin antibiotic.

In clinical trials cefilavancin has shown similar efficacy with reduced side effects compared to vancomycin itself.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370484191 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001370484191 · captured 2026-08-21 · ledger · version history

Cite this page as: encyclopegia.org, “Cefilavancin”, snapshot enwiki-001370484191. https://encyclopegia.org/a/cefilavancin

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.